![An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn0175/asset/9c9f6574-48c9-45d5-b88a-a563e40fb1d4/assets/images/large/sciimmunol.abn0175-f1.jpg)
An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology
![Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD | Mucosal Immunology Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD | Mucosal Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmi.2010.40/MediaObjects/41385_2010_Article_BFmi201040_Fig1_HTML.jpg)
Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD | Mucosal Immunology
![An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn0175/asset/5d6d416b-8cfc-40b4-af9d-d4f41da131e9/assets/images/large/sciimmunol.abn0175-f4.jpg)
An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology
![An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology](https://www.science.org/cms/asset/16162ac3-7cac-410a-b841-2c2f8a7303d5/keyimage.gif)
An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology
![2637 S Carroll Street, Philadelphia, PA 19142 | MLS PAPH2086320 | Listing Information | Long & Foster 2637 S Carroll Street, Philadelphia, PA 19142 | MLS PAPH2086320 | Listing Information | Long & Foster](https://realestatedigital.propertiescdn.com/ListingImages/mdbmls/images/398/0/PAPH2086320.jpg?ts=637943602200000000)
2637 S Carroll Street, Philadelphia, PA 19142 | MLS PAPH2086320 | Listing Information | Long & Foster
![Frontiers | Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies Frontiers | Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies](https://www.frontiersin.org/files/MyHome%20Article%20Library/689270/689270_Thumb_400.jpg)
Frontiers | Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies
![The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury - The American Journal of Pathology The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury - The American Journal of Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/322654e2-fd73-4c43-be68-f7382411716e/gr3_lrg.jpg)
The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury - The American Journal of Pathology
![An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn0175/asset/9e9dc502-b764-4cfd-98c7-3000314a8e89/assets/images/large/sciimmunol.abn0175-f2.jpg)